financetom
Business
financetom
/
Business
/
Cyclo Therapeutics to Receive European Patent for Alzheimer's Disease Treatment
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Cyclo Therapeutics to Receive European Patent for Alzheimer's Disease Treatment
Jul 29, 2024 7:20 AM

09:54 AM EDT, 07/29/2024 (MT Newswires) -- Cyclo Therapeutics ( CYTH ) said Monday it has been notified by the European Patent Office that it will be granted a European patent for its method of treating Alzheimer's disease.

The decision will be published on Aug. 21 and the patent will take effect on that date, the company said.

Shares of Cyclo Therapeutics ( CYTH ) were 2.6% lower in recent trading.

Price: 1.17, Change: +0.02, Percent Change: +1.74

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Cyclo Therapeutics to Receive European Patent for Alzheimer's Disease Treatment
Cyclo Therapeutics to Receive European Patent for Alzheimer's Disease Treatment
Jul 29, 2024
09:54 AM EDT, 07/29/2024 (MT Newswires) -- Cyclo Therapeutics ( CYTH ) said Monday it has been notified by the European Patent Office that it will be granted a European patent for its method of treating Alzheimer's disease. The decision will be published on Aug. 21 and the patent will take effect on that date, the company said. Shares of...
--Hewlett Packard to Get EU Approval for $14 Billion Juniper Networks Acquisition, Reuters Reports
--Hewlett Packard to Get EU Approval for $14 Billion Juniper Networks Acquisition, Reuters Reports
Jul 29, 2024
09:54 AM EDT, 07/29/2024 (MT Newswires) -- Price: 19.64, Change: -0.13, Percent Change: -0.63 ...
GSK Partners With Flagship Pioneering to Develop New Respiratory, Immunology Therapies
GSK Partners With Flagship Pioneering to Develop New Respiratory, Immunology Therapies
Jul 29, 2024
09:54 AM EDT, 07/29/2024 (MT Newswires) -- GSK (GSK) is partnering with bioplatform company Flagship Pioneering to identify and develop new medicines and vaccines, starting with prospective respiratory and immunology treatments, Flagship said Monday. The deal calls for GSK and Flagship to put $150 million toward an exploratory phase that would identify the ten most promising prospective medicines and vaccines...
Cannabix Up 18% After Saying in
Cannabix Up 18% After Saying in "Advanced" Talks to Distribute Breath Logix Device in Texas
Jul 29, 2024
09:59 AM EDT, 07/29/2024 (MT Newswires) -- Cannabix Technologies ( BLOZF ) , which is up 18% to $0.58 at last look, has begun discussions with Smartox of Irving, Texas for the potential sales distribution of its Breath Logix Alcohol screening device. Cannabix ( BLOZF ) has shipped its device for evaluation, preliminary marketing and business development purposes. Cannabix (...
Copyright 2023-2026 - www.financetom.com All Rights Reserved